Catalyst overview
Research summary
This catalyst tracks a Phase 2b data readout for ESK-001 in Systemic lupus erythematosus . The expected timing is based on the latest available company guidance and may change.
05/14/26:- LUMUS Ph2b SLE topline data remains expected in Q3 2026. 08/13/26:- LUMUS Ph2b SLE topline data remains expected in Q3 2026.
Verification
Confirm timing and program details against the company announcement or filing.